98%
921
2 minutes
20
Aims: The formation of lower limb arterial plaques, exacerbated by type 2 diabetes (T2D), represents an early stage of lower limb peripheral artery disease (PAD). Second near-infrared region (NIR-II) imaging is an emerging technique with high sensitivity for detecting perfusion levels. This study explores the value of NIR-II imaging in identifying perfusion changes due to lower extremity arterial plaques in T2D patients without PAD.
Methods: NIR-II imaging with indocyanine green (ICG) was conducted on 120 T2D patients, who were categorized into two groups: plaque and non-plaque. NIR-II parameters and clinical characteristics were analyzed between the two groups to identify significant predictors of lower extremity arterial plaques.
Results: Six NIR-II imaging parameters (T start, T 1/2, Tmax, Ingress rate, Egress, and Egress rate) showed significant differences and diagnostic efficacy between the two groups. Three NIR-II parameters (T start, Egress, and Egress rate) and two clinical characteristics (age and sex) were identified as independent predictors of lower limb artery plaques. The nomogram showed that a combined model with NIR-II parameters and clinical characteristics exhibited higher diagnostic efficacy.
Conclusion: NIR-II imaging can effectively detect early perfusion changes in T2D patients, showing great potential for pre-diagnosis of individuals at high risk for PAD.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.diabres.2025.112038 | DOI Listing |
Natl Sci Rev
August 2025
Center for AIE Research, Shenzhen Key Laboratory of Polymer Science and Technology, Guangdong Provincial Key Laboratory of New Energy Materials Service Safety, College of Material Science and Engineering, Shenzhen University, Shenzhen 518060, China.
Multimodal phototheranostics has been recognized as one of the most momentous advances in cancer treatment. Of particular interest is a single molecular species simultaneously featuring in multiple imaging and synergistic phototherapies; the development of such a molecular species is nevertheless a formidably challenging task. Herein, we innovatively designed and synthesized three aggregation-induced emission (AIE)-active molecules with emission in the second near-infrared (NIR-II) window, by employing 10-indeno[1,2-][1,2,5]thiadiazolo[3,4-]quinoxalin-10-one as the electron acceptor, 4-(-butyl)--(4-(-butyl)phenyl)--phenylaniline as the electron donor, and different π-bridge moieties.
View Article and Find Full Text PDFMater Today Bio
October 2025
School of Public Health, Key Laboratory of Emergency and Trauma of Ministry of Education, Hainan Medical University, Haikou, 571199, China.
The development of controllable nanoplatforms with disease-specific responsiveness and programmable therapeutic functions is vital for treating complex cardiovascular diseases such as atherosclerosis. Herein, we present an intelligent, next-generation nanoplatform (HALA@AgS) that integrates enzyme-responsive dual-drug delivery with NIR-II imaging-guided photothermal therapy (PTT), enabling triple-stimuli synergy of enzyme, light, and multi-drug co-activation. This modular design enables stable nanoassemblies with high drug-loading capacity and selective disassembly in enzyme-rich plaque microenvironments, achieving controlled dual-drug release exceeding 80 % within 72 h.
View Article and Find Full Text PDFJ Mater Chem B
September 2025
State Key Laboratory of Luminescent Materials and Devices, Guangdong Provincial Key Laboratory of Luminescence from Molecular Aggregates, College of Materials Science and Engineering, South China University of Technology, Guangzhou 510640, China.
Adenosine triphosphate (ATP) is a critical biomolecule in cellular energy metabolism, with abnormal levels in the bloodstream linked to pathological conditions such as ischemia, cancer, and inflammatory disorders. Accurate and real-time detection of ATP is essential for early diagnosis and disease monitoring. However, conventional biochemical assays and other techniques suffer from limitations, including invasive sample collection, time-consuming procedures, and the inability to provide dynamic, monitoring.
View Article and Find Full Text PDFBiomaterials
September 2025
Department of Radiology, Fifth Hospital of Shanxi Medical University, Shanxi Provincial People's Hospital, Taiyuan, 030000, China. Electronic address:
Acute liver injury (ALI) is a serious disease characterized by liver function impairment caused by multiple causes in a short period of time. Due to lack of precise diagnosis and timely intervention, many patients with ALI rapidly progress to liver dysfunction and liver failure. Here, a multifunctional silybin nano-prodrug, PTS@IR, was developed that integrated microenvironment-activatable second near-infrared (NIR-II) fluorescence (FL) imaging for precise diagnosis and timely therapy of ALI.
View Article and Find Full Text PDFJ Am Chem Soc
September 2025
National Engineering Research Centre for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, P. R. China.
Image-guided surgery plays a critical role in improving the cancer patient prognosis. However, current clinical probes are often single-modal with "always-on" signals, failing to provide complementary and precise guidance across all perioperative phases. To tackle this hurdle, we develop a biomarker-activatable, multimodal nanoprobe - - based on redox-mediated manganese valence switching for tumor-specific, perioperative image-guided surgery.
View Article and Find Full Text PDF